Display Settings:

Format

Send to:

Choose Destination
    AIDS Rev. 2009 Jul-Sep;11(3):157-64.

    Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.

    Source

    VU University Medical Center, Amsterdam, The Netherlands.

    Abstract

    Hyporesponsiveness (anti-HBs 10-100 IU/l) or non-responsiveness (anti-HBs < 10 IU/l) to hepatitis B vaccines is a problem in approximately 20-70% of HIV-positive patients. Mechanisms for impaired humoral and cellular immunity related to the HIV infection are reviewed. Contributing risk factors like age, gender, CD4+ T-cell count, HIV RNA load and coinfection with hepatitis C are highlighted. New developments in improving the HBV vaccine immunogenicity are discussed and clinical recommendations are given for HBV-re-vaccination of HIV patients who failed on standard HBV vaccination.

    PMID:
    19654857
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Permanyer Publications

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk